Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wellington Partners has invested in over fifty early/growth-stage life science companies since its founding in 1998. Their track record includes €590 million raised for life science funds and at least twenty-seven exits via IPO or trade sale. They focus on innovative technologies with strong management teams and products near or entering clinical trials. Their current fund WPLS V closed at €210 million and supports ambitious European healthcare startups across biotech, medtech, diagnostics, and digital health sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wellington Partners.